Top Markets
#1 Cysic Cysic +7.96%
#2 Palladium Network Palladium Network +6.82%
#3 Pieverse Pieverse +3.88%
#4 Akedo Akedo +2.15%
#5 Bless Bless +1.27%
#6 aPriori aPriori +1.17%
#7 Prom Prom +1.16%
#8 Zest Protocol Zest Protocol +1.01%
#9 Test Test +0.95%
#10 Open Campus Open Campus +0.84%
Coin of the day
Cysic Cysic
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Clasificación en acciones #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Precio por acción
$0.2301
Última sincronización: 2026-08-12
Capitalización bursátil
$228.81K
Cambio (1 día)
-17.82%
Cambio (1 año)
95,775.00%
País
US
Comercio The Greater Cannabis Company, Inc. (GCAN)

Categoría

Healthcare
Ganancias de The Greater Cannabis Company, Inc. (GCAN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di The Greater Cannabis Company, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de The Greater Cannabis Company, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US